Haier Biomedical Suzhou Expands Pharmacy Automation Solutions

CALIFORNIA, CA, UNITED STATES, October 22, 2026 /CourierPR/ -- Haier Biomedical Technology (Suzhou) Co., Ltd., a core intelligent pharmacy unit under Haier Biomedical, has established a robust brand moat in the pharmacy automation market. Founded in 2015, the company operates a 13,000 square meter facility in Suzhou, China, employing 500 individuals, including 100 R&D engineers.

The company has received European Union verifications of conformity for its automated dispensing systems, high-speed dispensing systems, and anaesthetic medication cabinets, valid until 2029 and 2030. These certifications cover specific equipment models and ensure compliance with stringent safety standards, providing hospitals with the assurance they need when selecting pharmacy automation solutions.

Pharmacy automation spending is concentrated in hospital settings, with hospital pharmacies identified as the largest segment of the market in 2024, driven by high patient volumes and complex medication regimens. The global pharmacy automation devices market was valued at USD 6.7 billion in 2024 and is projected to reach USD 11.6 billion by 2030, growing at a compound annual growth rate of 9.9%. At the product level, medication dispensing systems held the largest share at 32.5% in 2025, with automated medication compounding expected to grow at a CAGR above 10%.

Haier Biomedical Technology (Suzhou) reported total revenue of RMB 2.33 billion (approximately USD 340.77 million) in 2025, with overseas revenue of RMB 840 million, marking a 17.9% year-on-year increase. The company's product architecture covers outpatient dispensing, inpatient pharmacy storage and dispensing, automated PIVAS, and high-risk drug handling. Key products include the Robotic Arm Dispenser HOH-KF-Smart, capable of storing at least 20,000 boxes and dispensing at least 300 prescriptions per hour, and the Chute Type Dispenser HOH-KF-1200, which can store over 15,000 boxes within a footprint of under 12.85 square meters.

These solutions support integration with hospital information systems (HIS) and electronic medical records (EMR) platforms, ensuring seamless prescription data exchange. The company also offers a Fully Automated Cytotoxic Drug Compounding Robot HOH-Robot-Plus, designed to operate under Class 100 cleanroom conditions, with a compounding rate of 25 preparations per hour.

Haier Biomedical Technology (Suzhou) holds ISO 9001 and ISO 13485 medical device quality management system certification and CE marking. The company's solutions are in use in hospitals across Asia and other international markets, with documented deployments in Thailand and Vietnam, where they have demonstrated reduced patient waiting times and optimized dispensing workflows.

The company offers OEM, ODM, and full customization services, with a minimum order quantity of one unit and a lead time of 60 to 90 days. Post-delivery services include remote technical support, on-site installation and commissioning, operator training, software upgrades, and global after-sales service. Haier Biomedical Technology (Suzhou) Co., Ltd. continues to expand its presence in the global pharmacy automation market, driven by its comprehensive product portfolio and robust certifications.